Oncology Data Advisor
Cabozantinib/Atezolizumab for Metastatic Colorectal Cancer: Thomas Abrams, MD
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:05:52
- More information
Informações:
Synopsis
In this interview, Dr. Thomas Abrams of Harvard Medical School discusses the role that cabozantinib/atezolizumab may play for patients with metastatic colorectal cancer, particularly those with RAS wild-type disease, in the coming years.
